Our lawyers in Beijing represent Fortune Global 500 companies and financial institutions in cross-border transactions in the Greater China region. We also advise Chinese companies and financial institutions on their strategic outbound investments into the U.S., Europe, Latin America, and other global markets.
A LEADER IN ASIA
Paul Hastings was one of the first major international law firms to establish an Asia practice, and today we continue to be a leader in the region. Our Beijing team works closely with our offices in Hong Kong, Seoul, Shanghai, and Tokyo to advise clients throughout Asia.
M&A Deal of the Year: North AsiaThe American Lawyer
Asia M&A Law Firm of the YearThe American Lawyer
Capital Markets Law Firm of the YearChina Business Law Journal
Healthcare, Pharma & Life Sciences Law Firm of the YearChina Business Law Journal
Represented ICBC International in its investment into JD Logistics’ US$2.5B Series A financing.
Represented Ascent Real Estate Investors and SDP Investment in the formation of an institutional investor consortium and the consortium’s US$1.34B acquisition of Dinghao Electronics Plaza located in Zhongguancun, Beijing.
Represented Fosun Pharmaceutical in forming a strategic alliance with Biopharmaceutical New Technologies (BioNTech) to develop and commercialize a vaccine that prevents COVID-19 infections, and a proposed equity investment of ordinary shares in BioNTech.
The lawyers in ourMergers and Acquisitionspractice structure complex cross-border transactions and investments, and have been recognized in the Asian Legal Business M&A Rankings.
OurCapital Marketspractice advises some of the largest Chinese companies on a wide range of capital markets transactions, including Hong Kong, NYSE, and NASDAQ initial public offerings.
OurPrivate Investment Fundspractice serves fund sponsors, institutional investors, lenders, placement agents, and investment advisers, among others, in all aspects of structuring and documenting new private investment funds.